Record Details

Evaluation of health resources expenditure in two groups of psychotic patients treated with olanzapine and typical neuroleptics in a Italian Mental Health Department in Calabria Region

Farmeconomia

View Archive Info
 
 
Field Value
 
Title Evaluation of health resources expenditure in two groups of psychotic patients treated with olanzapine and typical neuroleptics in a Italian Mental Health Department in Calabria Region
 
Creator Caputo, Anna
Guidi, Luca
Biricolti, Giovanni
Torchia, Sergio
 
Subject Pharmacoeconomics; Health economics
Olanzapine; Typical neuroleptics; Global costs; Italian Mental Health Department
 
Description Numerous Italian and international trials have studied the global costs of treatment with olanzapine and typical neuroleptics. Our analysis confirms those results. In our study, treatment with olanzapine, as compared to typical neuroleptics, was associated with a greater reduction in emergency interventions (hospitalisations), with an increased use of rehabilitation services and with a small increase in the number of working days. The differences between the two groups for this variable were not great, while the differences in the assessment scores appeared important and statistically significant. The results of present study are relative to the practice of one Italian Mental Health Department and, for this reason, cannot be generalized. Anyway, they are another indication of increased efficiency of atypicals treatment over older neuroleptics in schizophrenia.
 
Publisher SEEd Medical Publishers
 
Contributor
 
Date 2008-03-15
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion

 
Format application/pdf
 
Identifier https://journals.edizioniseed.it/index.php/FE/article/view/214
10.7175/fe.v9i1.214
 
Source Farmeconomia. Health economics and therapeutic pathways; Vol 9, No 1 (2008); 41-47
2240-256X
 
Language eng
 
Relation https://journals.edizioniseed.it/index.php/FE/article/view/214/204
 
Coverage


 
Rights Copyright (c) 2008 Farmeconomia. Health economics and therapeutic pathways
http://creativecommons.org/licenses/by-nc/4.0